Latest Research On Parkinson's Disease
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In this discussion, Dr. Hill learns from Dr. William Burke about the latest research trying to link the dopamine theory to the alpha synuclean theory to better explain why Parkinson's Disease occurs. In this segment they also discuss current symptomatic treatment for Parkinson's Disease and the properties that would make up a more curative neuroprotective treatment.
Overview
In this discussion, Dr. Hill learns from Dr. William Burke about the latest research trying to link the dopamine theory to the alpha synuclean theory to better explain why Parkinson's Disease occurs. In this segment they also discuss current symptomatic treatment for Parkinson's Disease and the properties that would make up a more curative neuroprotective treatment.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Level Up Your Skills: Tailoring Management of HF
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Navigating Myasthenia Gravis in Adolescents and Young Adults
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?